Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in patients with acute myocardial infarction (MI). The present study shows that LCZ696 can prevent cardiac rupture after MI, probably due to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JACC Basic Transl Sci
Autori principali: Ishii, Masanobu, Kaikita, Koichi, Sato, Koji, Sueta, Daisuke, Fujisue, Koichiro, Arima, Yuichiro, Oimatsu, Yu, Mitsuse, Tatsuro, Onoue, Yoshiro, Araki, Satoshi, Yamamuro, Megumi, Nakamura, Taishi, Izumiya, Yasuhiro, Yamamoto, Eiichiro, Kojima, Sunao, Kim-Mitsuyama, Shokei, Ogawa, Hisao, Tsujita, Kenichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
PRECLINICAL RESEARCH
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059351/
https://ncbi.nlm.nih.gov/pubmed/30062181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2017.08.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi